Clinical Trial Update: Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1) [Phase 2]

View source ↗

Summary

Phase 2 multicenter randomized, double-masked, placebo-controlled trial evaluating YP-P10 ophthalmic solution for dry eye completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• YP-P10 Ophthalmic Solution

Snippet

Sponsor: Yuyu Pharma, Inc. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2024-07-30